BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 12750388)

  • 1. Tumor suppressor p53 and its homologue p73alpha affect cell migration.
    Sablina AA; Chumakov PM; Kopnin BP
    J Biol Chem; 2003 Jul; 278(30):27362-71. PubMed ID: 12750388
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p73 independent of c-Myc represses transcription of platelet-derived growth factor beta-receptor through interaction with NF-Y.
    Hackzell A; Uramoto H; Izumi H; Kohno K; Funa K
    J Biol Chem; 2002 Oct; 277(42):39769-76. PubMed ID: 12167641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of protein kinase A catalytic subunit beta as a novel binding partner of p73 and regulation of p73 function.
    Hanamoto T; Ozaki T; Furuya K; Hosoda M; Hayashi S; Nakanishi M; Yamamoto H; Kikuchi H; Todo S; Nakagawara A
    J Biol Chem; 2005 Apr; 280(17):16665-75. PubMed ID: 15723830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of Daxx interacting with p73, one of the p53 family, and its regulation of p53 activity by competitive interaction with PML.
    Kim EJ; Park JS; Um SJ
    Nucleic Acids Res; 2003 Sep; 31(18):5356-67. PubMed ID: 12954772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. deltaNp73 facilitates cell immortalization and cooperates with oncogenic Ras in cellular transformation in vivo.
    Petrenko O; Zaika A; Moll UM
    Mol Cell Biol; 2003 Aug; 23(16):5540-55. PubMed ID: 12897129
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p73 function is inhibited by tumor-derived p53 mutants in mammalian cells.
    Di Como CJ; Gaiddon C; Prives C
    Mol Cell Biol; 1999 Feb; 19(2):1438-49. PubMed ID: 9891077
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p73alpha is a candidate effector in the p53 independent apoptosis pathway of cisplatin damaged primary murine colonocytes.
    Oniscu A; Sphyris N; Morris RG; Bader S; Harrison DJ
    J Clin Pathol; 2004 May; 57(5):492-8. PubMed ID: 15113856
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p73alpha expression induces both accumulation and activation of wt-p53 independent of the p73alpha transcriptional activity.
    Miro-Mur F; Meiller A; Haddada H; May E
    Oncogene; 2003 Aug; 22(35):5451-6. PubMed ID: 12934105
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of direct p73 target genes combining DNA microarray and chromatin immunoprecipitation analyses.
    Fontemaggi G; Kela I; Amariglio N; Rechavi G; Krishnamurthy J; Strano S; Sacchi A; Givol D; Blandino G
    J Biol Chem; 2002 Nov; 277(45):43359-68. PubMed ID: 12213815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Function of p73, not of p53, is inhibited by the physical interaction with RACK1 and its inhibitory effect is counteracted by pRB.
    Ozaki T; Watanabe K; Nakagawa T; Miyazaki K; Takahashi M; Nakagawara A
    Oncogene; 2003 May; 22(21):3231-42. PubMed ID: 12761493
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p19Arf-p53 tumor suppressor pathway regulates cell motility by suppression of phosphoinositide 3-kinase and Rac1 GTPase activities.
    Guo F; Gao Y; Wang L; Zheng Y
    J Biol Chem; 2003 Apr; 278(16):14414-9. PubMed ID: 12578823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The ferredoxin reductase gene is regulated by the p53 family and sensitizes cells to oxidative stress-induced apoptosis.
    Liu G; Chen X
    Oncogene; 2002 Oct; 21(47):7195-204. PubMed ID: 12370809
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p73 transcriptional activity increases upon cooperation between its spliced forms.
    Alarcon-Vargas D; Fuchs SY; Deb S; Ronai Z
    Oncogene; 2000 Feb; 19(6):831-5. PubMed ID: 10698502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative analysis of p73 and p53 regulation and effector functions.
    Fang L; Lee SW; Aaronson SA
    J Cell Biol; 1999 Nov; 147(4):823-30. PubMed ID: 10562283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p73 competes with p53 and attenuates its response in a human ovarian cancer cell line.
    Vikhanskaya F; D'Incalci M; Broggini M
    Nucleic Acids Res; 2000 Jan; 28(2):513-9. PubMed ID: 10606650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Full-length p73alpha represses drug-induced apoptosis in small cell lung carcinoma cells.
    Nyman U; Sobczak-Pluta A; Vlachos P; Perlmann T; Zhivotovsky B; Joseph B
    J Biol Chem; 2005 Oct; 280(40):34159-69. PubMed ID: 16087678
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p73 Overexpression increases VEGF and reduces thrombospondin-1 production: implications for tumor angiogenesis.
    Vikhanskaya F; Bani MR; Borsotti P; Ghilardi C; Ceruti R; Ghisleni G; Marabese M; Giavazzi R; Broggini M; Taraboletti G
    Oncogene; 2001 Nov; 20(50):7293-300. PubMed ID: 11704858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of the p53 homolog p73 by adenoviral oncogene E1A.
    Das S; El-Deiry WS; Somasundaram K
    J Biol Chem; 2003 May; 278(20):18313-20. PubMed ID: 12639967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stabilization of p73 by nuclear IkappaB kinase-alpha mediates cisplatin-induced apoptosis.
    Furuya K; Ozaki T; Hanamoto T; Hosoda M; Hayashi S; Barker PA; Takano K; Matsumoto M; Nakagawara A
    J Biol Chem; 2007 Jun; 282(25):18365-18378. PubMed ID: 17452332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DN-p73 is activated after DNA damage in a p53-dependent manner to regulate p53-induced cell cycle arrest.
    Vossio S; Palescandolo E; Pediconi N; Moretti F; Balsano C; Levrero M; Costanzo A
    Oncogene; 2002 May; 21(23):3796-803. PubMed ID: 12032848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.